Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Naples (Italy it)
Oncology

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

8,701
Activity
3%

Total documents

2.44
Impact
3%

Normalized Impact

1,732
Excellence
3%

Highly Cited Papers (Top 10%)

61.9
Leadership
3%

Leadership (%)

38.2
Mobility & Collaboration
3%

International Collaboration (%)

262
Excellence
3%

Outstanding papers (Top 1%)

13.8
Leadership
3%

Women Leading (%)

3.0
Leadership
3%

Women Leading International (%)

53.2
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Ascierto, Paolo Antonio male Oncology Senior researcher 903 28 1,251 5.17 329 33.3% 58.6%
2 Falzone, Luca male Molecular Biology Researcher 903 10 128 12.59 52 25.0% 46.9%
3 Cascella, Marco male Surgery, Anesthesiology and Pain Medicine Leading researcher 898 43 340 3.07 61 58.5% 20.3%
4 Pignata, Sandro male Reproductive Medicine, Oncology Leading researcher 886 38 729 3.81 150 26.2% 38.8%
5 Normanno, Nicola male Oncology Leading researcher 873 35 518 2.75 98 41.3% 34.2%
6 Perrone, Francesco male Oncology Leading researcher 867 36 324 1.96 69 43.2% 25.0%
7 DE LAURENTIIS, Michelino male Oncology Leading researcher 861 32 544 2.45 109 18.9% 44.9%
8 Pinto, Antonio male Leading researcher 859 44 387 1.79 65 40.8% 29.2%
9 Izzo, Francesco male Hepatology, Oncology Leading researcher 851 36 397 2.19 93 32.8% 17.9%
10 Aprea, Pasquale male Emergency Medical Services, Molecular Biology Occasional author 847 17 11 0.81 0 0.0% 18.2%
11 Botti, Gerardo male Oncology Leading researcher 840 76 775 1.66 147 18.7% 19.4%
12 Malagutti, Nicola male Oncology Senior researcher 833 28 167 5.88 34 28.7% 28.1%
13 Granata, Vincenza female Radiology, Nuclear Medicine and Imaging Senior researcher 831 15 330 2.21 90 36.1% 9.7%
14 Morabito, Alessandro male Oncology, Pulmonary and Respiratory Medicine Leading researcher 826 62 396 1.97 67 22.0% 27.3%
15 Petrillo, Antonella female Radiology, Nuclear Medicine and Imaging Leading researcher 824 44 386 1.69 86 46.9% 12.7%
16 Delrio, Paolo male Oncology Leading researcher 823 32 313 2.34 65 18.2% 18.9%
17 Simeone, Ester female Oncology Senior researcher 820 20 214 4.11 40 11.2% 27.1%
18 Patrone, Renato male Surgery Researcher 817 11 93 2.99 27 14.0% 11.8%
19 Perri, Francesco male Oncology Leading researcher 813 42 343 1.73 36 34.1% 21.6%
20 Buonaguro, Luigi male Immunology, Molecular Biology, Epidemiology Leading researcher 808 44 446 1.21 61 50.9% 28.7%
21 Greggi, Stefano male Reproductive Medicine Leading researcher 802 43 232 3.37 56 21.6% 19.4%
22 Augustin, Livia Silvia Adriana female Public Health, Environmental and Occupational Health, Nutrition and Dietetics Researcher 794 43 167 2.06 33 26.4% 43.1%
23 Madonna, Gabriele female Oncology Researcher 792 14 101 1.81 23 8.9% 45.5%
24 PERDONĂ , SISTO male Pulmonary and Respiratory Medicine, Surgery Leading researcher 792 33 259 1.55 59 15.8% 27.8%
25 Ottaiano, Alessandro male Oncology Senior researcher 779 26 250 1.40 37 38.8% 14.8%
903
One Index
Ascierto, Paolo Antonio PhD   0000-0002-8322-475X 1251 docs (1997 - 2024)  
Melanoma , Biomarkers for Immunotherapy , Clinical endpoint , Immune Checkpoint Blockade , Immune checkpoint
903
One Index
Falzone, Luca PhD   0000-0001-7349-6826 128 docs (2015 - 2024)  
Diet Quality , Healthy Eating Index , Cancer , Mediterranean Diet , Immune Checkpoint Blockade
898
One Index
Cascella, Marco PhD   0000-0002-5236-3132 340 docs (1982 - 2024)  
Pain Management , Pain Assessment Tools , Cancer Pain , Postoperative Pain , Pain Modulation
886
One Index
Pignata, Sandro PhD   0000-0002-8836-2633 729 docs (1987 - 2024)  
Carboplatin , Clinical endpoint , Olaparib , Ovarian Cancer , Progression-free survival
873
One Index
Normanno, Nicola PhD   0000-0002-7158-2605 518 docs (1990 - 2024)  
EGFR Mutations , Metastatic Colorectal Cancer , Cancer Genomics , FOLFIRI , Breast Cancer
867
One Index
Perrone, Francesco PhD   0000-0002-9738-0526 324 docs (1989 - 2024)  
Carboplatin , Clinical endpoint , Letrozole , Breast Cancer , Non-Small Cell Lung Cancer
861
One Index
DE LAURENTIIS, Michelino PhD   0000-0001-9009-1572 544 docs (1993 - 2024)  
Breast Cancer , Metastatic Breast Cancer , Fulvestrant , Trastuzumab , Clinical endpoint
859
One Index
Pinto, Antonio PhD   0000-0002-9425-9026 387 docs (1981 - 2024)  
Refractory (planetary science) , Follicular lymphoma , Mantle Cell Lymphoma , Clinical endpoint , Rituximab
851
One Index
Izzo, Francesco PhD   0000-0003-3093-5408 397 docs (1989 - 2024)  
Hepatocellular Carcinoma , Electrochemotherapy , Cancer Imaging , Liver cancer , Radiofrequency Ablation
847
One Index
Aprea, Pasquale 11 docs (2008 - 2024)  
Central Venous Catheterization , Dacarbazine , Central venous catheter , Peripherally Inserted Central Catheters , Temsirolimus
840
One Index
Botti, Gerardo PhD   0000-0002-6287-733X 775 docs (1949 - 2024)  
Melanoma , Tumor Microenvironment , Cardiotoxicity , Breast Cancer , Biomarkers for Immunotherapy
833
One Index
Malagutti, Nicola PhD   0000-0002-6630-0706 167 docs (1997 - 2024)  
Melanoma , Sentinel Lymph Node Biopsy , Surgical oncology , Nonmelanoma Skin Cancer , Tumor Staging
831
One Index
Granata, Vincenza PhD   0000-0002-6601-3221 330 docs (2010 - 2024)  
Cancer Imaging , Breast MRI , Electrochemotherapy , Radiomics , Medical Imaging
826
One Index
Morabito, Alessandro PhD   0000-0002-1319-9608 396 docs (1963 - 2024)  
Afatinib , Clinical endpoint , EGFR Mutations , Carboplatin , Osimertinib
824
One Index
Petrillo, Antonella PhD   0000-0003-2465-5370 386 docs (1981 - 2024)  
Cancer Imaging , Breast MRI , Dynamic Contrast-Enhanced MRI , Diffusion-Weighted Imaging , Perfusion Imaging
823
One Index
Delrio, Paolo PhD   0000-0002-4271-4939 313 docs (1993 - 2024)  
Metastatic Colorectal Cancer , Neoadjuvant Therapy , Colorectal surgery , Rectal Cancer , Folinic acid
820
One Index
Simeone, Ester PhD   0000-0003-2964-0434 214 docs (2005 - 2024)  
Melanoma , Biomarkers for Immunotherapy , Dabrafenib , Electrochemotherapy , Trametinib
817
One Index
Patrone, Renato PhD   0000-0002-6969-4157 93 docs (2014 - 2024)  
Electrochemotherapy , Liver Resection , Pandemic , Lymphadenectomy , Liver Cancer
813
One Index
Perri, Francesco PhD   0000-0001-8158-7509 343 docs (1983 - 2024)  
Regimen , Cancer Therapy , Metastatic Colorectal Cancer , Radiotherapy , Chemoradiotherapy
808
One Index
Buonaguro, Luigi PhD   0000-0002-6380-7114 446 docs (1981 - 2024)  
HIV , Antigen Presentation , Cancer Immunotherapy , HPV Vaccination , Hepatocellular Carcinoma
802
One Index
Greggi, Stefano PhD   0000-0001-5601-5111 232 docs (1982 - 2024)  
Ovarian Cancer , Carboplatin , Lymphadenectomy , Endometrial Carcinoma , Cervical Cancer
794
One Index
Augustin, Livia Silvia Adriana PhD   0000-0002-6673-8281 167 docs (1982 - 2024)  
Glycemic load , Healthy Eating Index , Diet Quality , Dietary Patterns , Glycemic Index
792
One Index
Madonna, Gabriele PhD   0000-0001-9395-3190 101 docs (2011 - 2024)  
Tumor Regression , Biomarkers for Immunotherapy , Melanoma , T Cell Therapy , T Cell Immunity
792
One Index
PERDONĂ , SISTO PhD   0000-0001-8683-4644 259 docs (1992 - 2024)  
Prostate Cancer , Treatment , Bladder Cancer , Penile Cancer , Metastatic Bladder Cancer
779
One Index
Ottaiano, Alessandro PhD   0000-0002-2901-3855 250 docs (1999 - 2024)  
Metastatic Colorectal Cancer , Cancer Imaging , Clinical endpoint , Radiomics , FOLFIRI